Markus Grompe, M.D., is responsible for forward-thinking research on the use of in vivo selection to enhance gene and cell transplantation therapy in the liver, work for which he is known worldwide. An additional focus of Grompe’s work includes hepatic stem cells and their use in therapeutic liver repopulation. Ultimately, the goal of his work is to contribute to the development of innovative treatments for metabolic liver diseases, among others. He is currently a Professor at Oregon Health Sciences University and Director of the Oregon Stem Cell Center in the Papé Family Pediatric Research Institute. Grompe received his M.D. from the University of Ulm Medical School in Germany, trained in Pediatrics at Oregon Health Sciences University and Baylor College of Medicine, where he was a Fellow in the Pediatric Scientist Training Program in the Institute for Molecular Genetics. He has published over 200 articles in peer-reviewed publications, holds multiple patents, and has been honored with awards such as the E. Mead Johnson Award for pediatric research and the Merit Award of the Fanconi Anemia Research Foundation.